LONDON, Ontario, Jan. 07, 2020 (GLOBE NEWSWIRE) — Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) is pleased to announce that it has shipped its first cases of Sugarleaf by 7AC (“Sugarleaf”). In October 2019, Indiva announced that it had signed a definitive agreement (the “Agreement“) with The Supreme Cannabis Company, Inc. (“Supreme Cannabis”) (TSX:FIRE) (OTCQX:SPRWF) (FRA:53S1) to manufacture and distribute pre-rolls for Supreme Cannabis’ portfolio of brands from Indiva’s facility in London, Ontario. Sugarleaf’s rolled Jack Haze is the first product shipped under the Agreement.
Sugarleaf’s rolled Jack Haze is available in 1-gram pre-rolled joints and is manufactured using wood cones with a folded in, flat tip. In the near future, Indiva will also manufacture pre-rolls for 7AC’s Jean Guy, Sensi Star and White Widow strains. More information on Sugarleaf can be found at https://www.sugarleafby7ac.ca/.
Indiva sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, Indiva creates premium pre-rolls, flower, capsules, oils, sprays and edible products and provides production, manufacturing and refinement services to peer entities. In Canada, Indiva produces and distributes the award-winning Bhang® Chocolate, Ruby® Cannabis Sugar, Sapphire™ Cannabis Salt, Gems™, and other Powered by Indiva™ products through license agreements, partnerships and joint ventures. Click here to connect with Indiva on social media and here to find more information on the Company and its products.
Vice President of Communications
DISCLAIMER AND READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the matters set forth in this press release and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
The Company does not host, update or provide content for the web page https://www.sugarleafby7ac.ca/ and is in no way responsible for the adequacy or accuracy of the information or content contained therein or has in any way approved or disapproved of the contents contained therein.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company’s future product offerings and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to maintain the necessary regulatory and licensing and other risks associated with regulated entities in the cannabis industry. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The Company’s securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.